Sex difference in pulmonary hypertension in the evaluation by exercise echocardiography

Male patients with pulmonary hypertension have poor survival than their female counterparts. Poor right ventricular function in men may be one of the major determinants of poor prognosis. This study aimed to investigate the difference in hemodynamics during exercise between men and women by exercise echocardiography. Consecutive patients with pulmonary hypertension who underwent right heart catheterization were enrolled, and survival was analyzed. In patients who underwent exercise echocardiography, the change in tricuspid regurgitation pressure gradient during exercise was calculated at multiple stages (low-, moderate-, and high-load exercise), and the mortality was also recorded. In a total of 93 patients, although there were no differences in pulmonary artery pressure and vascular resistance between sexes, male patients showed poor survival. In patients with exercise echocardiography, change in tricuspid regurgitation pressure gradient at low-load (25 W) exercise was significantly lower in men, although that at maximum-load exercise was not different between men and women. In the Kaplan–Meier analysis, in a median follow-up duration of 1760 days, male patients and those with lower change in tricuspid regurgitation pressure gradient at low-load exercise showed poorer survival (P = 0.002 and 0.026, respectively). In the Cox proportional hazards analysis, the change in tricuspid regurgitation pressure gradient at low-load exercise was independently associated with poor survival after adjustment for age and sex. In conclusion, a lower change in tricuspid regurgitation pressure gradient at low-load exercise was observed in male patients and was a prognostic marker, which may be associated, at least in part, with poorer prognosis in male patients with pulmonary hypertension.

[1]  R. Rafikov,et al.  Necrosis-Released HMGB1 (High Mobility Group Box 1) in the Progressive Pulmonary Arterial Hypertension Associated With Male Sex , 2020, Hypertension.

[2]  T. Lahm,et al.  Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure. , 2019, Comprehensive Physiology.

[3]  Patty J. Lee,et al.  Cell Death in the Lung: The Apoptosis-Necroptosis Axis. , 2019, Annual review of physiology.

[4]  J. Cogan,et al.  The Y Chromosome Regulates BMPR2 Expression via SRY: A Possible Reason "Why" Fewer Males Develop Pulmonary Arterial Hypertension. , 2018, American journal of respiratory and critical care medicine.

[5]  S. Söderberg,et al.  A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension , 2018, European heart journal.

[6]  D. Fairweather,et al.  Sex differences in pulmonary arterial hypertension: role of infection and autoimmunity in the pathogenesis of disease , 2018, Biology of Sex Differences.

[7]  L. Uhlmann,et al.  Systolic pulmonary artery pressure assessed during routine exercise Doppler echocardiography: insights of a real-world setting in patients with elevated pulmonary pressures , 2018, The International Journal of Cardiovascular Imaging.

[8]  A. Arnold,et al.  The Y Chromosome Plays a Protective Role in Experimental Hypoxic Pulmonary Hypertension. , 2017, American journal of respiratory and critical care medicine.

[9]  M. Maclean,et al.  The Role of Sex in the Pathophysiology of Pulmonary Hypertension. , 2018, Advances in experimental medicine and biology.

[10]  A. Shah,et al.  Accuracy of Echocardiography to Estimate Pulmonary Artery Pressures With Exercise: A Simultaneous Invasive–Noninvasive Comparison , 2017, Circulation. Cardiovascular imaging.

[11]  Eugenio Picano,et al.  The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. , 2016, European heart journal cardiovascular Imaging.

[12]  Warren J. Manning,et al.  Right Ventricular Volumes and Systolic Function by Cardiac Magnetic Resonance and the Impact of Sex, Age, and Obesity in a Longitudinally Followed Cohort Free of Pulmonary and Cardiovascular Disease: The Framingham Heart Study , 2016, Circulation. Cardiovascular imaging.

[13]  D. Bluemke,et al.  Oestradiol metabolism and androgen receptor genotypes are associated with right ventricular function , 2015, European Respiratory Journal.

[14]  C. Fischer,et al.  Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension , 2014, Arthritis Research & Therapy.

[15]  I. Petrache,et al.  Progress in solving the sex hormone paradox in pulmonary hypertension. , 2014, American journal of physiology. Lung cellular and molecular physiology.

[16]  J. Marcus,et al.  The right ventricle explains sex differences in survival in idiopathic pulmonary arterial hypertension. , 2014, Chest.

[17]  C. Pabelick,et al.  Sex differences in the pulmonary circulation: implications for pulmonary hypertension. , 2014, American journal of physiology. Heart and circulatory physiology.

[18]  K. Mair,et al.  Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response , 2014, British journal of pharmacology.

[19]  C. Fischer,et al.  Assessment and Prognostic Relevance of Right Ventricular Contractile Reserve in Patients With Severe Pulmonary Hypertension , 2013, Circulation.

[20]  A. Praestgaard,et al.  Sex and haemodynamics in pulmonary arterial hypertension , 2013, European Respiratory Journal.

[21]  R. Naeije,et al.  Exercise-induced pulmonary hypertension: physiological basis and methodological concerns. , 2013, American journal of respiratory and critical care medicine.

[22]  J. Barberà,et al.  Survival in pulmonary hypertension in Spain: insights from the Spanish registry , 2012, European Respiratory Journal.

[23]  M. Eghbali,et al.  Estrogen rescues preexisting severe pulmonary hypertension in rats. , 2011, American journal of respiratory and critical care medicine.

[24]  V. A. de Jesus Perez Making sense of the estrogen paradox in pulmonary arterial hypertension. , 2011, American journal of respiratory and critical care medicine.

[25]  Christopher S Coffey,et al.  Predicting Survival in Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) , 2010, Circulation.

[26]  M. Humbert,et al.  Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension , 2010, European Respiratory Journal.

[27]  S. Bergmann,et al.  Determinants of right ventricular ejection fraction in pulmonary arterial hypertension. , 2009, Chest.

[28]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.